Everything about Darvocet totally explained
Dextropropoxyphene is an
analgesic in the
opioid category. It is used to treat mild to moderate pain and as an
anti-tussive. It can be used to ease surgical pain both prophylactically and palliatively. It is possible to classify it as a mild opioid pain-killer, however it's considered no more effective than
aspirin in treating pain.
Dextropropoxyphene is sometimes combined with
paracetamol (acetaminophen) or
aspirin. Trade-names include
Darvocet-N for dextropropoxyphene and
paracetamol and
Darvon-N with ASA for dextropropoxyphene and
aspirin. It is also sometimes sold in combination with caffeine in order to boost pain control.
There is no
peer-reviewed evidence that this combination is any more effective than
paracetamol alone. There is significant anecdotal evidence from patients that
Darvocet is more effective than paracetamol, but a third of patients suffering chronic pain report relief from that pain when treated with placebo.
It is manufactured and marketed by
Eli Lilly and Company.
It is an
optical isomer of
levopropoxyphene. The
racemic mixture is called propoxyphene.
Some preparations that contain dextropropoxyphene include
Distalgesic and
Doloxene.
Indications
Analgesia
Dextropropoxyphene, like
codeine, is a "weak" opioid. Codeine is more commonly used; however, some individuals (approximately 10-20% of the
Caucasian population) are unable to metabolize it, due to poor functioning of the enzyme
CYP2D6. It is in these people that dextropropoxyphene is particularly useful, as its metabolism doesn't require CYP2D6.
Restless Legs Syndrome
Propoxyphene has been found to be helpful in relieving the symptoms of
Restless legs syndrome (RLS).
Opioid withdrawal
In pure form, dextropropoxyphene is commonly used to ease the
withdrawal symptoms in people addicted to opioids. Being very weak in comparison to the opioids that are commonly abused, dextropropoxyphene can only act as a "partial" substitute. It doesn't have much effect on mental cravings; however it can be effective in alleviating physical withdrawal effects, such as muscle cramps.
Dextropropoxyphene is subject to some controversy: while many
physicians prescribe it for a wide range of mildly to moderately painful symptoms as well as for treatment of
diarrhea, many others refuse to prescribe it, citing limited effectiveness.
The
therapeutic index of dextroproxyphene is relatively small. In the
UK, dextropropoxyphene and co-proxamol are now discouraged from general use; and, since 2004, preparations containing only dextropropoxyphene have been discontinued. This has been a somewhat controversial decision, since it has caused abusers to switch to the combined product and risk paracetamol toxicity.
Australia declined to follow suit and opted to allow pure dextropropoxyphene to remain available by prescription. From 31st December 2007, in the UK
co-proxamol is only available on a named patient basis, for long term chronic pain and only to those who have already been prescribed this medicine. Its withdrawal from the UK market is a result of concerns relating to its toxicity in overdose (even small overdose can be fatal), and dangerous reaction with alcohol. Recreational use in the UK is uncommon. Many patients have been prescribed alternative combinations of more potent drugs.
In the
United States, dextropropoxyphene HCl is available as a prescription formulation with
paracetamol (acetaminophen) in ratio anywhere from 30 mg / 600 mg to 100 mg / 650 mg (or 100 mg / 325 mg in the case of Balacet), respectively. These are usually named "Darvocet." On the other hand, "Darvon" is a pure propoxyphene preparation available in the U.S. that doesn't contain paracetamol.
In Australia, dextropropoxyphene is available on prescription, both as a combined product (32.5mg dextropropoxyphene per 325mg
paracetamol branded as either "Di-gesic", "Capadex", and "Paradex," it's also available in pure form (100 mg capsules) known as "Doloxene".
Adverse effects
Darvocet overdose is commonly broken into two categories:
liver toxicity (from
paracetamol poisoning) and dextropropoxyphene overdose. Many users experience toxic effects from the
paracetamol (acetaminophen) in pursuit of the endlessly-increasing dose required to achieve
euphoria. They suffer acute
liver toxicity, which causes severe
stomach pains,
nausea, and
vomiting (all of which are increased by light or stimulation of the sense of sight).
As with all opioid tablets containing
paracetamol or
aspirin, risk of liver toxicity (from acetaminophen) or gastrointestinal irritation and ulcers (from aspirin) can be minimized by a simple
cold water extraction technique.
Dextropropoxyphene also has several other non-opioid side-effects.
Both propoxyphene and its metabolite norpropoxyphene, have local
anesthetic effects at concentrations about 10 times those necessary for opioid effects. In this respect,
norpropoxyphene is more potent than propoxyphene, and they're both more potent than
lidocaine.
Both propoxyphene and norpropoxyphene also have direct cardiac effects which include decreased
heart rate, decreased
contractility, and decreased
electrical conductivity (ie, increased PR, AH, HV, and QRS intervals). Norpropoxyphene is several times more potent than propoxyphene in this activity. These effects appear to be due to their local anesthetic activity and are not reversed by
naloxone.
Both propoxyphene and norpropoxyphene are potent blockers of
cardiac membrane sodium channels and are more potent than
lidocaine,
quinidine, and
procainamide in this respect.
Propoxyphene and norpropoxyphene appear to have the characteristics of a
Vaughan Williams Class Ic antiarrhythmic.
Darvon, a dextropropxyphene made by
Eli Lilly, which had been on the market for 25 years, came under heavy fire in 1978 by consumer groups that said it was associated with
suicide. Darvon was never withdrawn from the market, but Lilly has waged a sweeping, and largely successful, campaign among doctors, pharmacists and Darvon users to defend the drug as safe when it's used in proper doses and not mixed with alcohol.
In
Sweden physicians have been discouraged by the medical products agency to prescribe dextropropoxyphene due to the risk of respiratory depression when taken with alcohol. [http://www.lakemedelsverket.se/Tpl/NewsPage
6275.aspx
Fatal deaths; DXP in medico legal material: http://www.lakemedelsverket.se/upload/nyheter/2007/figur1_dextropropoxifen_dödsfall.gif
The sales of DXP in Sweden, 2000-2006: http://www.lakemedelsverket.se/upload/nyheter/2007/figur3_dextropropoxifen_försäljningsdata.gif
On November 28th 2007 a video at YouTube – http://www.youtube.com - was released: Darvon, Distalgesic, Co-Proxamol . The worst drugs ever. http://www.youtube.com/results?search_query=jonasson+darvon&search_type=
Recreational use
Those who take dextropropoxyphene for recreational purposes take larger than therapeutic doses and, if it isn't
extracted, the
paracetamol (acetaminophen) that's present in combination products can be
toxic to the liver. Some adverse effects of recreational dextropropoxyphene use are: a persistent
dry mouth,
decreased appetite,
urinary retention and
constipation that may lead to
diverticulitis.
Further Information
Get more info on 'Darvocet'.
|
External Link Exchanges
Do you know how hard it is to get a link from a large encyclopaedia? Well we're different and will prove it. To get a link from us just add the following HTML to your site on a relevant page:
<a href="http://dextropropoxyphene.totallyexplained.com">Dextropropoxyphene Totally Explained</a>
Then simply click through this link from your web page. Our crawlers will verify your link, extract the title of your web page and instantly add a link back to it. If you like you can remove the words Totally Explained and embed the link in article text.
As long as your link remains in place, we'll keep our link to you right here. Please play fair - our crawlers are watching. Your site must be closely related to this one's topic. Any kind of spamming, dubious practises or removing the link will result in your link from us being dropped and, potentially, your whole site being banned. |